XML 41 R28.htm IDEA: XBRL DOCUMENT
v3.22.2

GOODWILL AND INTANGIBLE ASSETS (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract] |
Schedule of Goodwill | The following table summarizes the changes in the carrying amount of Goodwill:
(in millions) |  | Amount |
Balance as of December 31, 2021 |  | $ | 8,332 |  |
Measurement period adjustments |  | (18) |  |
Balance as of June 30, 2022 |  | $ | 8,314 |  |
Schedule of Finite-Lived Intangible Assets | The following table summarizes our Intangible assets, net:
|  | June 30, 2022 |  | December 31, 2021
(in millions) |  | Gross Carrying Amount |  | Accumulated Amortization |  | Foreign Currency Translation Adjustment |  | Net Carrying Amount |  | Gross Carrying Amount |  | Accumulated Amortization |  | Foreign Currency Translation Adjustment |  | Net Carrying Amount
Finite-lived assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Intangible asset – sofosbuvir |  | $ | 10,720 |  |  | $ | (6,001) |  |  | $ | — |  |  | $ | 4,719 |  |  | $ | 10,720 |  |  | $ | (5,651) |  |  | $ | — |  |  | $ | 5,069 |
Intangible asset – axicabtagene ciloleucel |  | 7,110 |  |  | (1,704) |  |  | — |  |  | 5,406 |  |  | 7,110 |  |  | (1,501) |  |  | — |  |  | 5,609 |
Intangible asset – Trodelvy |  | 5,630 |  |  | (740) |  |  | — |  |  | 4,890 |  |  | 5,630 |  |  | (507) |  |  | — |  |  | 5,123 |
Intangible asset – Hepcludex |  | 845 |  |  | (115) |  |  | — |  |  | 730 |  |  | 845 |  |  | (72) |  |  | — |  |  | 773 |
Other |  | 1,614 |  |  | (695) |  |  | 1 |  |  | 920 |  |  | 1,610 |  |  | (650) |  |  | 1 |  |  | 961 |
Total finite-lived assets |  | 25,919 |  |  | (9,254) |  |  | 1 |  |  | 16,665 |  |  | 25,915 |  |  | (8,381) |  |  | 1 |  |  | 17,535 |
Indefinite-lived assets – IPR&D |  | 13,220 |  |  | — |  |  | — |  |  | 13,220 |  |  | 15,920 |  |  | — |  |  | — |  |  | 15,920 |
Total intangible assets |  | $ | 39,139 |  |  | $ | (9,254) |  |  | $ | 1 |  |  | $ | 29,885 |  |  | $ | 41,835 |  |  | $ | (8,381) |  |  | $ | 1 |  |  | $ | 33,455 |
Schedule of Indefinite-Lived Intangible Assets | The following table summarizes our Intangible assets, net:
|  | June 30, 2022 |  | December 31, 2021
(in millions) |  | Gross Carrying Amount |  | Accumulated Amortization |  | Foreign Currency Translation Adjustment |  | Net Carrying Amount |  | Gross Carrying Amount |  | Accumulated Amortization |  | Foreign Currency Translation Adjustment |  | Net Carrying Amount
Finite-lived assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Intangible asset – sofosbuvir |  | $ | 10,720 |  |  | $ | (6,001) |  |  | $ | — |  |  | $ | 4,719 |  |  | $ | 10,720 |  |  | $ | (5,651) |  |  | $ | — |  |  | $ | 5,069 |
Intangible asset – axicabtagene ciloleucel |  | 7,110 |  |  | (1,704) |  |  | — |  |  | 5,406 |  |  | 7,110 |  |  | (1,501) |  |  | — |  |  | 5,609 |
Intangible asset – Trodelvy |  | 5,630 |  |  | (740) |  |  | — |  |  | 4,890 |  |  | 5,630 |  |  | (507) |  |  | — |  |  | 5,123 |
Intangible asset – Hepcludex |  | 845 |  |  | (115) |  |  | — |  |  | 730 |  |  | 845 |  |  | (72) |  |  | — |  |  | 773 |
Other |  | 1,614 |  |  | (695) |  |  | 1 |  |  | 920 |  |  | 1,610 |  |  | (650) |  |  | 1 |  |  | 961 |
Total finite-lived assets |  | 25,919 |  |  | (9,254) |  |  | 1 |  |  | 16,665 |  |  | 25,915 |  |  | (8,381) |  |  | 1 |  |  | 17,535 |
Indefinite-lived assets – IPR&D |  | 13,220 |  |  | — |  |  | — |  |  | 13,220 |  |  | 15,920 |  |  | — |  |  | — |  |  | 15,920 |
Total intangible assets |  | $ | 39,139 |  |  | $ | (9,254) |  |  | $ | 1 |  |  | $ | 29,885 |  |  | $ | 41,835 |  |  | $ | (8,381) |  |  | $ | 1 |  |  | $ | 33,455 |
Schedule of Estimated Future Amortization Expense | The following table summarizes the estimated future amortization expense associated with our finite-lived intangible assets as of June 30, 2022:
(in millions) |  | Amount
2022 (remaining six months) |  | $ | 891 |
2023 |  | 1,781 |
2024 |  | 1,781 |
2025 |  | 1,776 |
2026 |  | 1,768 |
Thereafter |  | 8,669 |
Total |  | $ | 16,665 |

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275 + Details
Name: | us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (h) -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (g) -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1A -URI https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267 Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 2 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267 Reference 11: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 55 -Paragraph 24 -URI https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268 Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 + Details
Name: | us-gaap_ScheduleOfGoodwillTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 3 -Subparagraph (b),(d) -URI https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275 + Details
Name: | us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275 + Details
Name: | us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration